Jason Cavalier

Chief Financial Officer, Lyra Therapeutics, Inc.

Companies

Lyra Therapeutics, Inc.Principal Financial Officer Apr 3, 2026 to now¹
Lyra Therapeutics, Inc.Chief financial officer Sep 15, 2021 to now²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Lyra Therapeutics, Inc.517,880 shares³Apr 1, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

Apr 1, 2026Returned to company 667 shares of Lyra Therapeutics, Inc.³
Jan 6, 2026Sold 769 shares at $3.36 of Lyra Therapeutics, Inc.⁴
Jul 10, 2025Sold 684 shares at $8.91 of Lyra Therapeutics, Inc.⁵
Jan 8, 2025Granted 420,000 shares of Lyra Therapeutics, Inc.⁶
Oct 16, 2024Granted 100,000 shares of Lyra Therapeutics, Inc.⁷

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARLyra Therapeutics, Inc., Principal Financial Officer
2
SEC EDGARLyra Therapeutics, Inc., Chief financial officer
3
SEC EDGARLyra Therapeutics, Inc. shares after the filing of Apr 1, 2026
4
SEC EDGARForm 4 filed Jan 8, 2026
5
SEC EDGARForm 4 filed Jul 14, 2025
6
SEC EDGARForm 4 filed Jan 10, 2025
7
SEC EDGARForm 4 filed Oct 18, 2024